Used in neuroscience research to quantify levels of beta-secretase 1 (BACE1) activity in biological samples, particularly in studies related to Alzheimer’s disease. Helps researchers assess BACE1 expression in cell cultures, brain tissue, or cerebrospinal fluid, supporting investigation into amyloid plaque formation. Commonly applied in drug development to evaluate the efficacy of BACE1 inhibitors. Provides a reliable, high-throughput method for monitoring disease progression and therapeutic responses in experimental models.